These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 1678253)

  • 1. Characteristics of multidrug resistance in Plasmodium and Leishmania: detection of P-glycoprotein-like components.
    Grogl M; Martin RK; Oduola AM; Milhous WK; Kyle DE
    Am J Trop Med Hyg; 1991 Jul; 45(1):98-111. PubMed ID: 1678253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure.
    Grögl M; Oduola AM; Cordero LD; Kyle DE
    Exp Parasitol; 1989 Jul; 69(1):78-90. PubMed ID: 2543590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemistry of Pentostam resistant Leishmania.
    Berman JD; Edwards N; King M; Grogl M
    Am J Trop Med Hyg; 1989 Feb; 40(2):159-64. PubMed ID: 2537584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
    Grogl M; Thomason TN; Franke ED
    Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucantime resistant Leishmania promastigotes are sensitive to pentostam.
    Moreira ES; Guerra JB; Petrillo-Peixoto Mde L
    Rev Soc Bras Med Trop; 1992; 25(4):247-50. PubMed ID: 1340539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydro-beta-agarofuran sesquiterpenes: a new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania.
    Cortés-Selva F; Jiménez IA; Munoz-Martínez F; Campillo M; Bazzocchi IL; Pardo L; Ravelo AG; Castanys S; Gamarro F
    Curr Pharm Des; 2005; 11(24):3125-39. PubMed ID: 16178749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.
    Ephros M; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1997 May; 41(5):1064-8. PubMed ID: 9145870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance and P-glycoproteins in parasitic protozoa.
    Ullman B
    J Bioenerg Biomembr; 1995 Feb; 27(1):77-84. PubMed ID: 7629055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum: detection of P-glycoprotein in chloroquine-susceptible and chloroquine-resistant clones and isolates.
    Cremer G; Basco LK; Le Bras J; Camus D; Slomianny C
    Exp Parasitol; 1995 Aug; 81(1):1-8. PubMed ID: 7628557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tissue culture system for the growth of several species of Leishmania: growth kinetics and drug sensitivities.
    Martinez S; Looker DL; Marr JJ
    Am J Trop Med Hyg; 1988 Mar; 38(2):304-7. PubMed ID: 2833127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents.
    Pérez-Victoria JM; Di Pietro A; Barron D; Ravelo AG; Castanys S; Gamarro F
    Curr Drug Targets; 2002 Aug; 3(4):311-33. PubMed ID: 12102602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania mexicana: chemistry and biochemistry of sodium stibogluconate (Pentostam).
    Berman JD; Grogl M
    Exp Parasitol; 1988 Oct; 67(1):96-103. PubMed ID: 2844580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic resistance to diverse antimalarials in actinomycin D-resistant Plasmodium falciparum.
    Abrahem A; Certad G; Pan X; Georges E
    Biochem Pharmacol; 2000 May; 59(9):1123-32. PubMed ID: 10704942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis.
    Martinez S; Looker DL; Berens RL; Marr JJ
    Am J Trop Med Hyg; 1988 Sep; 39(3):250-5. PubMed ID: 2845824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines.
    Ferreira-Pinto KC; Miranda-Vilela AL; Anacleto C; Fernandes AP; Abdo MC; Petrillo-Peixoto ML; Moreira ES
    Can J Microbiol; 1996 Sep; 42(9):944-9. PubMed ID: 8864217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitizers in drug transport mechanisms involved in protozoan resistance.
    Pradines B; Pagès JM; Barbe J
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):411-31. PubMed ID: 16535862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ABC transporter genes of Plasmodium falciparum and drug resistance.
    Peel SA
    Drug Resist Updat; 2001 Feb; 4(1):66-74. PubMed ID: 11512154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole.
    Cowman AF; Karcz S; Galatis D; Culvenor JG
    J Cell Biol; 1991 Jun; 113(5):1033-42. PubMed ID: 1674943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance in natural isolates of Leishmania donovani s.l. promastigotes is dependent of Pgp170 expression.
    Messaritakis I; Christodoulou V; Mazeris A; Koutala E; Vlahou A; Papadogiorgaki S; Antoniou M
    PLoS One; 2013; 8(6):e65467. PubMed ID: 23776486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of cytosolic tryparedoxin peroxidase in antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum lines.
    Andrade JM; Murta SM
    Parasit Vectors; 2014 Aug; 7():406. PubMed ID: 25174795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.